QUOTED. 6 August 2019. Katherine Owen.
In the second quarter of 2019, Stryker reported a 6% growth in sales of orthopedic devices, led by the Mako robotic surgery platform. See what Katherine Owen, Stryker's VP of strategy and investor relations, said about it here.
“We think we're going to continue to see some strong gains in hips on Mako, as well as, obviously, with knees.” – Katherine Owen, VP of strategy and investor relations, Stryker
Click here for a free trial of Medtech Insight